First prospective study of a combined immune therapy of checkpoint inhibitors ± CTX plus Viscum album L. in non-small cell lung cancer (NSCLC) in UICC stage III B-IV B
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
3
References
0
Citations
NaN
KQI